191 related articles for article (PubMed ID: 36710099)
1. Diabetes is associated with increased burden of gastrointestinal symptoms in adults with cystic fibrosis.
Caley LR; Zagoya C; Duckstein F; White H; Shimmin D; Jones AM; Barrett J; Whitehouse JL; Floto RA; Mainz JG; Peckham DG
J Cyst Fibros; 2023 Mar; 22(2):275-281. PubMed ID: 36710099
[TBL] [Abstract][Full Text] [Related]
2. Elexacaftor-Tezacaftor-Ivacaftor Treatment Reduces Abdominal Symptoms in Cystic Fibrosis-Early results Obtained With the CF-Specific CFAbd-Score.
Mainz JG; Zagoya C; Polte L; Naehrlich L; Sasse L; Eickmeier O; Smaczny C; Barucha A; Bechinger L; Duckstein F; Kurzidim L; Eschenhagen P; Caley L; Peckham D; Schwarz C
Front Pharmacol; 2022; 13():877118. PubMed ID: 35721187
[No Abstract] [Full Text] [Related]
3. Validity and Reliability of a Novel Multimodal Questionnaire for the Assessment of Abdominal Symptoms in People with Cystic Fibrosis (CFAbd-Score).
Jaudszus A; Zeman E; Jans T; Pfeifer E; Tabori H; Arnold C; Michl RK; Lorenz M; Beiersdorf N; Mainz JG
Patient; 2019 Aug; 12(4):419-428. PubMed ID: 30887269
[TBL] [Abstract][Full Text] [Related]
4. New Concepts in the Pathogenesis of Cystic Fibrosis-Related Diabetes.
Moheet A; Moran A
J Clin Endocrinol Metab; 2022 May; 107(6):1503-1509. PubMed ID: 35106591
[TBL] [Abstract][Full Text] [Related]
5. Multicenter prospective study showing a high gastrointestinal symptom burden in cystic fibrosis.
Moshiree B; Freeman AJ; Vu PT; Khan U; Ufret-Vincenty C; Heltshe SL; Goss CH; Schwarzenberg SJ; Freedman SD; Borowitz D; Sathe M;
J Cyst Fibros; 2023 Mar; 22(2):266-274. PubMed ID: 36319569
[TBL] [Abstract][Full Text] [Related]
6. Cystic Fibrosis-Related Diabetes Workshop: Research Priorities Spanning Disease Pathophysiology, Diagnosis, and Outcomes.
Putman MS; Norris AW; Hull RL; Rickels MR; Sussel L; Blackman SM; Chan CL; Ode KL; Daley T; Stecenko AA; Moran A; Helmick MJ; Cray S; Alvarez JA; Stallings VA; Tuggle KL; Clancy JP; Eggerman TL; Engelhardt JF; Kelly A
Diabetes; 2023 Jun; 72(6):677-689. PubMed ID: 37125945
[TBL] [Abstract][Full Text] [Related]
7. Cystic Fibrosis-Related Diabetes Workshop: Research Priorities Spanning Disease Pathophysiology, Diagnosis, and Outcomes.
Putman MS; Norris AW; Hull RL; Rickels MR; Sussel L; Blackman SM; Chan CL; Ode KL; Daley T; Stecenko AA; Moran A; Helmick MJ; Cray S; Alvarez JA; Stallings VA; Tuggle KL; Clancy JP; Eggerman TL; Engelhardt JF; Kelly A
Diabetes Care; 2023 Jun; 46(6):1112-1123. PubMed ID: 37125948
[TBL] [Abstract][Full Text] [Related]
8. Effect of CFTR modulator therapy on cystic fibrosis-related diabetes.
Gaines H; Jones KR; Lim J; Medhi NF; Chen S; Scofield RH
J Diabetes Complications; 2021 Jun; 35(6):107845. PubMed ID: 33558149
[TBL] [Abstract][Full Text] [Related]
9. Cystic fibrosis related diabetes in Europe: Prevalence, risk factors and outcome; Olesen et al.
Olesen HV; Drevinek P; Gulmans VA; Hatziagorou E; Jung A; Mei-Zahav M; Stojnic N; Thomas M; Zolin A;
J Cyst Fibros; 2020 Mar; 19(2):321-327. PubMed ID: 31680042
[TBL] [Abstract][Full Text] [Related]
10. Dynamics of abdominal symptoms during the start of a new therapy with elexacaftor/tezacaftor/ivacaftor using the novel CFAbd-day2day questionnaire.
Mainz JG; Barucha A; Huang P; Bechinger L; Duckstein F; Polte L; Sadrieh P; Nährlich L; Eickmeier O; Van Dullemen S; Eschenhagen P; Schwarz C; Lüth S; Zagoya C; Graepler-Mainka U
Front Pharmacol; 2023; 14():1167407. PubMed ID: 38026920
[No Abstract] [Full Text] [Related]
11. The course of glucose intolerance in children with cystic fibrosis: a retrospective study - preliminary report.
Piechowiak K; Trippenbach-Dulska H; Walicka-Serzysko K
Dev Period Med; 2015; 19(1):80-91. PubMed ID: 26003073
[TBL] [Abstract][Full Text] [Related]
12. A high prevalence of chronic gastrointestinal symptoms in adults with cystic fibrosis is detected using tools already validated in other GI disorders.
Hayee B; Watson KL; Campbell S; Simpson A; Farrell E; Hutchings P; Macedo P; Perrin F; Whelan K; Elston C
United European Gastroenterol J; 2019 Aug; 7(7):881-888. PubMed ID: 31428412
[TBL] [Abstract][Full Text] [Related]
13. CF-related diabetes: Containing the metabolic miscreant of cystic fibrosis.
Moheet A; Moran A
Pediatr Pulmonol; 2017 Nov; 52(S48):S37-S43. PubMed ID: 28714601
[TBL] [Abstract][Full Text] [Related]
14. Canadian Cystic Fibrosis-related Diabetes Clinical Practice Survey: Analysis of Current Practices and Gaps in Clinical Care.
Potter KJ; Coriati A; Hicks P; Lands LC; McKinney ML; Boudreau V; Bonhoure A; Luca P; Ho J; Tagougui S; Jober A; Pohl M; Rosolowsky ET; Gilmour J; Lam GY; Stephenson AL; Senior PA; Rabasa-Lhoret R; Kherani T
Can J Diabetes; 2023 Apr; 47(3):263-271.e1. PubMed ID: 36872137
[TBL] [Abstract][Full Text] [Related]
15. Genetic Modifiers of Cystic Fibrosis-Related Diabetes Have Extensive Overlap With Type 2 Diabetes and Related Traits.
Aksit MA; Pace RG; Vecchio-Pagán B; Ling H; Rommens JM; Boelle PY; Guillot L; Raraigh KS; Pugh E; Zhang P; Strug LJ; Drumm ML; Knowles MR; Cutting GR; Corvol H; Blackman SM
J Clin Endocrinol Metab; 2020 May; 105(5):1401-15. PubMed ID: 31697830
[TBL] [Abstract][Full Text] [Related]
16. Staphylococcus aureus and Pseudomonas aeruginosa co-infection is associated with cystic fibrosis-related diabetes and poor clinical outcomes.
Limoli DH; Yang J; Khansaheb MK; Helfman B; Peng L; Stecenko AA; Goldberg JB
Eur J Clin Microbiol Infect Dis; 2016 Jun; 35(6):947-53. PubMed ID: 26993289
[TBL] [Abstract][Full Text] [Related]
17. Abdominal Symptoms Assessed With the CFAbd-Score are Associated With Intestinal Inflammation in Patients With Cystic Fibrosis.
Jaudszus A; Pfeifer E; Lorenz M; Beiersdorf N; Hipler UC; Zagoya C; Mainz JG
J Pediatr Gastroenterol Nutr; 2022 Mar; 74(3):355-360. PubMed ID: 34789668
[TBL] [Abstract][Full Text] [Related]
18. Cystic fibrosis-related diabetes mellitus: etiology, evaluation, and management.
Fischman D; Nookala VK
Endocr Pract; 2008 Dec; 14(9):1169-79. PubMed ID: 19158056
[TBL] [Abstract][Full Text] [Related]
19. Lumacaftor/ivacaftor therapy is associated with reduced hepatic steatosis in cystic fibrosis patients.
Kutney K; Donnola SB; Flask CA; Gubitosi-Klug R; O'Riordan M; McBennett K; Sferra TJ; Kaminski B
World J Hepatol; 2019 Dec; 11(12):761-772. PubMed ID: 31966908
[TBL] [Abstract][Full Text] [Related]
20. Cystic fibrosis-related diabetes onset can be predicted using biomarkers measured at birth.
Lin YC; Keenan K; Gong J; Panjwani N; Avolio J; Lin F; Adam D; Barrett P; Bégin S; Berthiaume Y; Bilodeau L; Bjornson C; Brusky J; Burgess C; Chilvers M; Consunji-Araneta R; Côté-Maurais G; Dale A; Donnelly C; Fairservice L; Griffin K; Henderson N; Hillaby A; Hughes D; Iqbal S; Itterman J; Jackson M; Karlsen E; Kosteniuk L; Lazosky L; Leung W; Levesque V; Maille É; Mateos-Corral D; McMahon V; Merjaneh M; Morrison N; Parkins M; Pike J; Price A; Quon BS; Reisman J; Smith C; Smith MJ; Vadeboncoeur N; Veniott D; Viczko T; Wilcox P; van Wylick R; Cutting G; Tullis E; Ratjen F; Rommens JM; Sun L; Solomon M; Stephenson AL; Brochiero E; Blackman S; Corvol H; Strug LJ
Genet Med; 2021 May; 23(5):927-933. PubMed ID: 33500570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
